MET and cancer: Among the candidates, genes of c-met and MCL-1, which have been reported to be associated with TRAIL sensitivity to several cancers [21, 22], were commonly predicted by all of these databases and contain complementary sequences paired with miR-101 at the 3’ UTR (Figure 2A).